Celyad Oncology S.A.
Celyad Oncology S.A. (CLYYF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CLYYF · as of Jun 9, 2026
Key Statistics
Explore Celyad Oncology S.A. Data
clyyf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 50.0%
Competitors & Peers
clyyf competitorsCLYYF
ADTX
ALLR
BWV
CHNXF
CLAZFStock Performance
Full HistoryAbout Celyad Oncology S.A.
Celyad Oncology S.A. Celyad Oncology SA is a clinical-stage biopharmaceutical entity dedicated to the discovery and advancement of chimeric antigen receptor T (CAR-T) cell therapies for cancer treatment. Its prominent cli…
what is celyad oncology s.a. · clyyf stock overview · celyad oncology s.a. company profile · who is celyad oncology s.a. ceo · clyyf OTC · celyad oncology s.a. headquarters · celyad oncology s.a. business segments
About Stock Overview & Key Data
Celyad Oncology S.A. (CLYYF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 15, 2014. As of the latest trading session, CLYYF stock price is $0.25, with a market capitalization of $11.2M. The stock has returned -50.00% over the past 12 months and +66.67% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Celyad Oncology S.A. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Celyad Oncology S.A. reported revenue of $20991.00 and net income of $829688.00. For detailed data — including Celyad Oncology S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Celyad Oncology S.A. (CLYYF) stock price is $0.25. The stock is traded on OTC under the ticker symbol CLYYF. The 52-week range is $0.15 – $0.53.